IOL Chemicals and Pharmaceuticals · NSE: IOLCP · BSE: 524164
Q2 FY26 results · Jul–Sep 2025
IOL Chemicals and Pharmaceuticals reported revenue from operations of ₹567.53 crore (up 7.9% from Q2 FY25) and net profit of ₹29.97 crore (up 56.5% from Q2 FY25) for Q2 FY26 (Jul–Sep 2025), on a consolidated basis.
| Item | Q2 FY26 | Q2 FY25 | YoY | Q1 FY26 | QoQ |
|---|---|---|---|---|---|
| Revenue from operations | 567.53 | 525.75 | +7.9% | 551.69 | +2.9% |
| Other income | 6.88 | 6.43 | +7.0% | 7.37 | −6.6% |
| Total income | 574.41 | 532.18 | +7.9% | 559.06 | +2.7% |
| Profit before tax | 40.49 | 25.94 | +56.1% | 45.51 | −11.0% |
| Net profit for the period | 29.97 | 19.15 | +56.5% | 33.93 | −11.7% |
| EPS, basic (₹) | 1.02 | 3.26 | not comparable | 1.16 | −12.1% |
| Net margin (%) | 5.3 | 3.6 | 6.2 |
| Item | Q2 FY26 | Q2 FY25 | YoY | Q1 FY26 | QoQ |
|---|---|---|---|---|---|
| Revenue from operations | 567.53 | 525.75 | +7.9% | 551.69 | +2.9% |
| Other income | 6.88 | 6.43 | +7.0% | 7.37 | −6.6% |
| Total income | 574.41 | 532.18 | +7.9% | 559.06 | +2.7% |
| Profit before tax | 40.52 | 25.94 | +56.2% | 45.54 | −11.0% |
| Net profit for the period | 30.00 | 19.15 | +56.7% | 33.96 | −11.7% |
| EPS, basic (₹) | 1.02 | 3.26 | not comparable | 1.16 | −12.1% |
| Net margin (%) | 5.3 | 3.6 | 6.2 |
Consolidated
- Filed with BSE
- 11 Nov 2025, 16:53 IST
- Board meeting
- 11 Nov 2025
- Period
- 01 Jul 2025 to 30 Sep 2025
- Review status
- Unaudited
- Source
- XBRL filing on BSE
Standalone
- Filed with BSE
- 11 Nov 2025, 16:53 IST
- Board meeting
- 11 Nov 2025
- Period
- 01 Jul 2025 to 30 Sep 2025
- Review status
- Unaudited
- Source
- XBRL filing on BSE